Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Regenerative Medicine

Regenerative Medicine Research

Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.

Showing 331-340 of 2,298 results

Spinal Cord InjuryRegenerative MedicineNeurology

Does CNS Myelin Inhibit Axon Regeneration?

Neuroscientist, 1999 • January 1, 1999

The review discusses the inhibitory effects of CNS myelin and reactive astrocytes on axon regeneration after injury. It highlights the role of molecules like NI-35/250 in myelin and chondroitin sulfat...

KEY FINDING: Molecules derived from myelin inhibit axon outgrowth. A high-molecular-weight membrane protein (NI-35/250) has been found in rat, bovine, and human myelin as a main neurite growth inhibitory factor.

Read Summary
Spinal Cord InjuryRegenerative MedicineNeurology

Transplantation of Wnt5a‑modified Bone Marrow Mesenchymal Stem Cells Promotes Recovery After Spinal Cord Injury via the PI3K/AKT Pathway

Molecular Neurobiology, 2024 • May 25, 2024

This study investigates the potential of Wnt5a-modified bone marrow mesenchymal stem cells (BMSCs) to promote recovery after spinal cord injury (SCI) by enhancing neuronal differentiation and reducing...

KEY FINDING: Wnt5a enhances neuronal differentiation of BMSCs in vitro while reducing astrocyte differentiation.

Read Summary
Regenerative MedicineNeurology

Neurogenic potential of NG2 in neurotrauma: a systematic review

Neural Regeneration Research, 2024 • March 1, 2024

This systematic review investigates the potential of NG2 cells to differentiate into neurons in models of traumatic brain injury (TBI) and spinal cord injury (SCI). It summarizes findings from 11 sel...

KEY FINDING: NG2 cells possess an inducible neurogenic potential in animal models and in vitro, and this can be promoted by pharmacological and genetic approaches.

Read Summary
Spinal Cord InjuryRegenerative MedicineHealthcare

Adverse events of cell therapy clinical trials in human chronic spinal cord injury, a systematic review and meta-analysis

Regenerative Therapy, 2024 • March 15, 2024

This study analyzed the AE of 14 types of cell therapy clinical trials in human chronic spinal cord injury and showed that in 45 studies of 76 reviewed articles, 64 types of AEs in 12 categories were ...

KEY FINDING: The most common adverse events were transient backache and meningism (90%) and cord malacia (80%).

Read Summary
Spinal Cord InjuryRegenerative MedicineBiomedical

Treatment of spinal cord injury with biomaterials and stem cell therapy in non-human primates and humans

Neural Regeneration Research, 2025 • May 24, 2024

This review examines therapeutic strategies for traumatic SCI regeneration in non-human primates (NHP) and pilot studies in humans, emphasizing cell transplantation and functional biomaterials. The re...

KEY FINDING: Stem cell-based transplantation shows promise due to direct tissue replacement, neuroprotection, and support for axonal regrowth and neuronal plasticity.

Read Summary
Spinal Cord InjuryRegenerative MedicineNeurology

Chondroitinase ABC combined with Schwann cell transplantation enhances restoration of neural connection and functional recovery following acute and chronic spinal cord injury

NEURAL REGENERATION RESEARCH, 2025 • June 3, 2024

This study investigates the efficacy of combining Schwann cell (SC) transplantation with chondroitinase ABC (ChABC) to enhance neural repair and functional recovery following spinal cord injury (SCI) ...

KEY FINDING: Chondroitinase ABC (ChABC) treatment effectively degraded CSPGs, reduced glial response, and promoted the migration of grafted Schwann cells (SCs) in the injured spinal cord.

Read Summary
Regenerative MedicineNeurology

Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3

Biomedicines, 2021 • November 24, 2021

This study evaluated the therapeutic potential of human mesenchymal stem cells (hMSCs) and their secretome (CM) in treating Spinocerebellar Ataxia type 3 (SCA3/MJD) using a mouse model. The results sh...

KEY FINDING: A single CM administration to the cerebellum had a mild effect on the balance and motor deficits of SCA3/MJD mice.

Read Summary
Spinal Cord InjuryRegenerative Medicine

Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury

Cell Reports Medicine, 2024 • December 17, 2024

This study reports the long-term results for a phase 1 study of neural stem cell transplantation for chronic spinal cord injury. Here, we report that all four subjects tolerated the stem cell implanta...

KEY FINDING: All four subjects tolerated the stem cell implantation procedure well, with no serious adverse events immediately following the procedure.

Read Summary
Spinal Cord InjuryRegenerative Medicine

Using magnetic resonance relaxometry to evaluate the safety and quality of induced pluripotent stem cell‑derived spinal cord progenitor cells

Stem Cell Research & Therapy, 2024 • November 20, 2024

This study introduces MRR as a rapid, label-free method for assessing the safety and quality of iPSC-derived SCPCs by measuring intracellular iron levels. The results demonstrate that MRR can effectiv...

KEY FINDING: Intracellular iron levels are significantly different between iPSCs and SCPCs, allowing MRR to distinguish between the two cell types based on T2 values.

Read Summary
Spinal Cord InjuryRegenerative MedicineGenetics

TET3‑facilitated differentiation of human umbilical cord mesenchymal stem cells into oligodendrocyte precursor cells for spinal cord injury recovery

Journal of Translational Medicine, 2024 • December 3, 2024

This study demonstrated that TET3-mediated demethylation reshapes the methylation patterns of HUCMSCs, enabling their efficient one-step conversion into OPCs and significantly reducing the time requir...

KEY FINDING: TET3 enhances HUCMSC differentiation into OPCs, evidenced by specific marker expression.

Read Summary
Previous
1...333435...230
Next